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STATE-OF-THE-ART PAPERS STATE-OF-THE-ART PAPERS1715Genetic Susceptibility to CADRobert Roberts, Alexandre F. R. Stewart
Susceptibility of coronary artery disease (CAD) is thought to be 40% to 60% inherited, but
the genetic risk factors predisposing to CAD remain undefined. The availability of
microarrays of single nucleotide polymorphisms enabling genome-wide association studies
(GWAS) led to the discovery of 33 genetic risk variants for CAD. Surprisingly, 23 risk
variants mediate their risk through unknown mechanisms, with only 10 associating with
hypertension or lipids. The first risk variant discovered by GWAS was 9p21.3 with a mean
increased risk of 25% per copy. Roberts and Stewart review the current utility of genetic
testing for cardiovascular risk and future directions of this field, which will likely lead to the
identification of novel pathways that increase cardiovascular risk independent of diet, sex, age,
cholesterol, or blood pressure.STATE-OF-THE-ART PAPERS1722Percutaneous Treatment of PFO and ASDsJonathan Tobis, Michael Shenoda
Percutaneous treatment of interatrial septal defects has experienced exponential growth in the
past 2 decades. Improved percutaneous devices, interventional techniques, and low
complication rates make this procedure an attractive therapeutic option for congenital atrial
septal defects (ASDs). Tobis and Shenoda review the anatomy and indications for catheter-
based ASD closure. The indications for catheter-based patent foramen ovale (PFO) closure
are still evolving. Results from 2 randomized clinical trials question the benefits of
percutaneous PFO closure, but the authors review questions raised about the efficacy of the
particular device used in the trials and the need for further trials.(continued on page A-16)
OCTOBER 30, 2012 (continued) A-16CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1733PCB Angioplasty Appears Effective in a Large Prospective RegistryJochen Wöhrle, Mariusz Zadura, Sven Möbius-Winkler, Matthias Leschke, Christian Opitz, Waqas Ahmed,
Paul Barragan, Jean-Philippe Simon, Graham Cassel, Bruno Scheller
In small randomized trials, paclitaxel coated balloon (PCB) angioplasty was superior to
uncoated balloon angioplasty for treatment of bare-metal stent (BMS) and drug-eluting stent
(DES) restenosis. Wöhrle and colleagues report the safety and efficacy of PCB angioplasty in
an international, multicenter, prospective, registry study. In 75 centers, 2,095 patients were
treated with PCB. Target lesion revascularization (TLR) rate was 5.2% after mean 9.4
months; vessel thrombosis occurred in 0.1%. TLR rate was significantly lower in patients with
PCB angioplasty for BMS restenosis compared with DES restenosis. In de-novo lesions
(small vessels), TLR rate was 1.0% with PCB alone and 2.4% in patients with additional
BMS implantation. These registry results confirm a low rate of TLR with PCB, especially for
the treatment of BMS restenosis.INTERVENTIONAL CARDIOLOGY1739DEB for the Treatment of Superficial Femoral Artery ISREugenio Stabile, Vittorio Virga, Luigi Salemme, Angelo Cioppa, Vittorio Ambrosini, Giovanni Sorropago,
Tullio Tesorio, Linda Cota, Grigore Popusoi, Armando Pucciarelli, Giancarlo Biamino, Paolo Rubino
The use of drug-eluting balloons (DEBs) has shown promising results in reducing restenosis
in coronary stents. This prospective registry evaluated the safety and efficacy of DEB for the
treatment of superficial femoral artery (SFA) in-stent restenosis (ISR). A total of
39 consecutive patients were treated for SFA ISR with final post-dilation with
paclitaxel-eluting balloons. Primary patency rate at 12 months was 92%, and all patients
were asymptomatic for claudication. These results suggest that adjunctive use of DEB for
the treatment of SFA ISR can reduce the risk of recurrent restenosis, but a randomized
trial is needed.(continued on page A-17)
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1743Predictive Factors and Long-Term Consequences of LBBB
Branch Block Following TAVI With a Balloon-Expandable ValveMarina Urena, Michael Mok, Vicenc Serra, Eric Dumont, Luis Nombela-Franco, Robert DeLarochellière,
Daniel Doyle, Albert Igual, Eric Larose, Ignacio Amat-Santos, Mélanie Côté, Hug Cuéllar,
Philippe Pibarot, Peter de Jaegere, François Philippon, Bruno Garcia del Blanco, Josep Rodés-Cabau
Urena and colleagues reviewed records from over 200 subjects who underwent transcatheter
aortic valve implantation (TAVI) with a balloon-expandable valve (BEV) to determine if
there are any predictive factors for new-onset persistent left bundle branch block (LBBB)
after the procedure. New-onset LBBB was observed in approximately one-third of patients
immediately after TAVI, and had resolved in 38% and 57% of them at hospital discharge and
at 6- to 12-month follow-up, respectively. Baseline QRS duration and prosthesis ventricular
depth were independent predictors of persistent LBBB. Patients with persistent LBBB and
who did not undergo permanent pacemaker implantation (PPI) prior to hospital discharge
had a higher incidence of syncope (16.0% vs. 0.7%, p  0.001) and complete AVB requiring
PPI (20.0% vs. 0.7%, p  0.001), but not of global mortality, cardiac mortality, or sudden
eath.ditorial Comment: Antonio Colombo, Azeem Latib, p. 1753MYOCARDIAL INFARCTION1756Perceived Stress Associated With Risk of Death After Myocardial InfarctionSuzanne V. Arnold, Kim G. Smolderen, Donna M. Buchanan, Yan Li, John A. Spertus
In a cohort of 4,204 acute myocardial infarction (AMI) patients from 24 U.S. hospitals,
Arnold and colleagues had subjects complete the Perceived Stress Scale-4 during
hospitalization. AMI patients with moderate/high stress had increased 2-year mortality
compared to those having low levels of stress (12.9% vs. 8.6%). This association persisted
after adjusting for sociodemographics, clinical factors (including depressive symptoms),
revascularization status, and GRACE discharge risk scores. Moderate/high stress at the time
of an AMI increases the risk of subsequent mortality.(continued on page A-18)
OCTOBER 30, 2012 (continued) A-18HEART FAILURE1764The LVAD Ramp StudyNir Uriel, Kerry A. Morrison, Arthur R. Garan, Tomoko Kato, Melana Yuzefpolskaya, Farhana Latif,
Susan W. Restaino, Donna M. Mancini, Margaret Flannery, Hiroo Takayama, Ranjit John,
Paolo C. Colombo, Yoshifumi Naka, Ulrich P. Jorde
Uriel and colleagues developed a standardized clinical ramp test protocol to be done at the
time of hospital discharge for speed optimization or if device malfunction is suspected in
patients with a continuous-flow left ventricular assist device. During echocardiography, the
speed of the device is increased in 400 rpm increments. Measurements collected include the
slopes (change in x/y on a graph) of the left ventricular end-diastolic dimension, pulsatility
index, and power at increasing speeds. The standardized ramp test was found to be both safe
and feasible. Speed changes were made in 61% of patients when the test was performed for
speed optimization. The test was found to be highly sensitive and specific for the detection of
device thrombosis.Editorial Comment: Joseph G. Rogers, Carmelo A. Milano, p. 1776HEART FAILURE1778Peripheral Endothelial Dysfunction Linked to Prognosis in Patients With HFNEFEiichi Akiyama, Seigo Sugiyama, Yasushi Matsuzawa, Masaaki Konishi, Hiroyuki Suzuki,
Toshimitsu Nozaki, Keisuke Ohba, Junichi Matsubara, Hirofumi Maeda, Yoko Horibata, Kenji Sakamoto,
Koichi Sugamura, Megumi Yamamuro, Hitoshi Sumida, Koichi Kaikita, Satomi Iwashita, Kunihiko Matsui,
Kazuo Kimura, Satoshi Umemura, Hisao Ogawa
Akiyama and colleagues investigated whether peripheral endothelial dysfunction could predict
the risk of cardiovascular events in patients with heart failure with normal left ventricular
ejection fraction (HFNEF). Peripheral endothelial function was assessed noninvasively as the
reactive hyperemia index (RHI) using peripheral arterial tonometry (RH-PAT). Kaplan-
Meier analysis demonstrated a significantly higher probability of cardiovascular events in the
low-RHI group than in the high-RHI group. Peripheral endothelial dysfunction was
independently associated with the risk of cardiovascular events in HFNEF patients.
Editorial Comment: Carolyn S. P. Lam, Dirk L. Brutsaert, p. 1787(continued on page A-19)
OCTOBER 30, 2012 (continued) A-19HEART RHYTHM DISORDERS1790Colchicine Prevents Early AF Recurrence After Pulmonary Vein IsolationSpyridon Deftereos, Georgios Giannopoulos, Charalambos Kossyvakis, Michael Efremidis,
Vasiliki Panagopoulou, Andreas Kaoukis, Konstantinos Raisakis, Georgios Bouras, Christos Angelidis,
Andreas Theodorakis, Metaxia Driva, Konstantinos Doudoumis, Vlasios Pyrgakis, Christodoulos Stefanadis
Deftereos and colleagues tested the utility of colchicine, an agent with potent anti-
inflammatory action, to reduce atrial fibrillation (AF) recurrence after pulmonary vein
isolation in patients with paroxysmal AF. After radiofrequency ablation treatment, subjects
were randomized to a 3-month course of colchicine, 0.5 mg twice daily, or placebo.
Recurrence of AF was observed in 33% of patients in the placebo group compared to 16% of
patients who received colchicine. These results suggest that colchicine is an effective and safe
treatment for prevention of early AF recurrences after pulmonary vein isolation.Editorial Comment: Gregory M. Marcus, Jonathan C. Hsu, p. 1797HEART RHYTHM DISORDERS
1799Elevated Pre-Operative Serum Peptides for Collagen I and III Synthesis
Associated With Post-Surgical AFMichael F. Swartz, Gregory W. Fink, Muhammad F. Sarwar, George L. Hicks, Yao Yu, Rui Hu,
Charles J. Lutz, Steven M. Taffet, José Jalife
Swartz and colleagues recently demonstrated that the risk of atrial fibrillation (AF) after
cardiac surgery is predicted by the degree of left atrial (LA) fibrosis. This study sought to
determine if serum markers for collagen I and III synthesis, the C-terminal peptide from pro-
collagen-I (PICP) and the N-terminal peptide from pro-collagen III (PIIINP), correlate with
LA fibrosis and post-operative AF. A total of 54 patients having cardiac surgery without a
history of AF consented to left and right atrial biopsies, and a pre-operative peripheral blood
draw. LA mRNA transcripts for collagen I, III, transforming growth factor, and angiotensin
were 1.5- to 2.0-fold higher in AF patients. Serum PICP and PIIINP levels were higher in
AF versus NSR. This study confirms that serum PICP and PIIINP levels correlate with the
presence of left atrial fibrosis and predict the risk of post-operative AF.
Editorial Comment: Jonathan M. Kalman, Saurabh Kumar, Prashanthan Sanders, p. 1807(continued on page A-20)
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tHEART RHYTHM DISORDERS1809CRT Reduces the Risk of Ventricular Tachyarrhythmic Events in MADIT-CRTGregory Ouellet, David T. Huang, Arthur J. Moss, W. Jackson Hall, Alon Barsheshet, Scott McNitt,
Helmut Klein, Wojciech Zareba, Ilan Goldenberg
Ouellet and colleagues evaluated the effect of cardiac resynchronization therapy with
defibrillator (CRT-D) on the risks of first and recurrent ventricular tachyarrhythmic events
(VTE) in MADIT-CRT. Multivariate analysis showed that CRT-D was associated with a
29% reduction in the risk of a first VTE, with a pronounced effect among patients with
LBBB (hazard ratio [HR]: 0.58) and no significant effect among non–LBBB patients
(HR: 1.05). Patients with LBBB who experienced a first VTE had no change in the risk of
subsequent VTEs with CRT-D, but this risk was increased in non–LBBB patients.
CRT-D was associated with a significant reduction in the risk of life-threatening VTEs, but
does not reduce the risk of subsequent VTEs in patients who experience a first arrhythmic
event, and may increase subsequent arrhythmic risk in non–LBBB patients.HEALTH SERVICES RESEARCH
1817The Impact of Reducing Cardiovascular Medication Copayments
on Health Spending and Resource UtilizationNiteesh K. Choudhry, Michael A. Fischer, Jerry L. Avorn, Joy L. Lee, Sebastian Schneeweiss,
Daniel H. Solomon, Christine Berman, Saira Jan, Joyce Lii, John J. Mahoney, William H. Shrank
Reducing copayments for post-myocardial infarction secondary prevention has beneficial
effects, but the impact of this strategy for lower-risk patients remains unclear. Choudhry and
colleagues evaluated health care spending and resource use by a large self-insured employer
that reduced statin copayments for patients with diabetes or vascular disease and reduced
clopidogrel copayments for all patients prescribed this drug. Eligible individuals in the
intervention company (n  3,513) were compared to a control group from other companies
without such a policy (n  49,803). Lowering copayments was associated with significant
reductions in rates of physician visits and hospitalizations/emergency department admissions,
but not major coronary events. Lowering copayments for statins and clopidogrel was
associated with reductions in health care resource use and patient out-of-pocket spending, and
was cost-neutral with respect to overall health spending.Editorial Comment: Eric C. Stecker, Eric M. Riles, A. Mark Fendrick, p. 1825CARDIAC IMAGING1828Rb-82 PET Has Superior Accuracy to SPECT for the Diagnosis of Obstructive CADBrian A. Mc Ardle, Taylor F. Dowlsey, Robert A. deKemp, George A. Wells, Rob S. Beanlands
Positron emission tomography (PET) using rubidium (Rb)-82 has potential advantages over
single-photon emission tomography (SPECT) that may make it more accurate and that
reduce radiation exposure compared to SPECT. Mc Ardle and colleagues performed a
systematic review of studies where either Rb-82 PET or technetium-99m SPECT with both
attenuation correction and ECG-gating were used with invasive coronary angiography (ICA)
as the reference standard. A total of 15 PET and 8 SPECT studies (n  1,344 and n 
,755, respectively) were included. The sensitivities for PET and SPECT were 90% and 85%
ith specificities of 88% and 85%, respectively. Rb-82 PET appears to be more accurate for
he detection of obstructive CAD than SPECT using current technology.
